Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Interest Expenses (2019 - 2025)

Silo Pharma's Interest Expenses history spans 6 years, with the latest figure at $886.0 for Q3 2025.

  • For Q3 2025, Interest Expenses fell 18.04% year-over-year to $886.0; the TTM value through Sep 2025 reached $4874.0, down 4.11%, while the annual FY2024 figure was $5084.0, 4.42% up from the prior year.
  • Interest Expenses for Q3 2025 was $886.0 at Silo Pharma, down from $1648.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $2066.0 in Q1 2025 and bottomed at $164.0 in Q4 2021.
  • The 4-year median for Interest Expenses is $1081.0 (2024), against an average of $1172.6.
  • The largest YoY upside for Interest Expenses was 504.65% in 2021 against a maximum downside of 99.94% in 2021.
  • A 4-year view of Interest Expenses shows it stood at $164.0 in 2021, then skyrocketed by 66.46% to $273.0 in 2023, then grew by 0.37% to $274.0 in 2024, then skyrocketed by 223.36% to $886.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Interest Expenses are $886.0 (Q3 2025), $1648.0 (Q2 2025), and $2066.0 (Q1 2025).